Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Hanmi Pharm. Co., Ltd.
Hanmi Pharmaceutical develops and sells prescription medicines, biologics, and manufacturing services for other drugmakers.
Hanmi Pharmaceutical is a South Korean drugmaker that sells prescription medicines — both original specialty drugs and cheaper generic copies — along with biologic medicines and contract manufacturing services for other companies. Its main customers are hospitals, clinics, and pharmacies in Korea, and increasingly partners and buyers in China, Japan, and the United States.
The company is best known for its push into innovative medicines, especially in metabolic disease and oncology. Its most famous asset is a class of long-acting drugs for diabetes and obesity, built on a technology that keeps a medicine working in the body for longer so patients inject or take it less often. Hanmi licensed one of these to a large global partner, and those deals — plus its own pipeline — are what investors watch most closely. Beyond its own drugs, Hanmi earns money making medicines for other firms. Its contract development and manufacturing arm produces biologics and other products for outside companies, a business that turns Hanmi's factories and know-how into steady fee income rather than one-off drug sales. That mix gives it both the upside of a research-driven pharma and the steadier cash of a manufacturer.
The risks are the classic ones for a drugmaker: clinical trials can fail, regulators can say no, and a single disappointing result can erase years of spending. Hanmi's bet is that its long-acting technology and its manufacturing base will keep paying off as demand for diabetes and obesity treatments keeps climbing worldwide.
Saved answer · last researched 12 Nov 2026